Fatigue in chronic disease

被引:269
作者
Swain, MG [1 ]
机构
[1] Univ Calgary, Gastroenterol Res Grp, Liver Unit, Calgary, AB T2N 4N1, Canada
关键词
anxiety; corticotropin-releasing hormone; cytokines; depression; fatigue; hypothalamic-pituitary-adrenal axis; inflammation; mood disorder; neurotransmitter;
D O I
10.1042/CS19990372
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fatigue is an extremely common complaint among patients with chronic disease. However, because of the subjective nature of fatigue, and the lack of effective therapeutics with which to treat fatigue, this symptom is often ignored by clinicians, who instead focus on hard, objective disease end-points. Recently, the symptom of fatigue has received greater attention as part of overall health-related quality of life assessments in patients with chronic disease. Furthermore, new methods are being developed to help quantify fatigue, and are being utilized more frequently in the clinical setting. Moreover, studies in patients and using animal models of disease have provided some insight into changes within the brain which appear to be linked to the genesis of central fatigue. This review focuses on fatigue in chronic disease and outlines possible mechanisms which may give rise to central fatigue in chronic disease. Moreover, methods for measuring fatigue and an approach to the fatigued patient are discussed. Hopefully, a broader understanding of th is distressing symptom will lead to the development of specific therapies for treating fatigue in these patients.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 104 条
  • [21] Cook N F, 1997, Br J Nurs, V6, P811
  • [22] Serum IL-6, TNFα, p55 srTNFα, p75 srTNFα, srIL-2α levels and disease acitivity in systemic lupus erythematosus
    Davas, EM
    Tsirogianni, A
    Kappou, I
    Karamitsos, D
    Economidou, I
    Dantis, PC
    [J]. CLINICAL RHEUMATOLOGY, 1999, 18 (01) : 17 - 22
  • [23] Deale A, 1997, AM J PSYCHIAT, V154, P408
  • [24] Denburg SD, 1997, J RHEUMATOL, V24, P998
  • [25] RESTLESS SLEEP, ILLNESS INTRUSIVENESS, AND DEPRESSIVE SYMPTOMS IN 3 CHRONIC ILLNESS CONDITIONS - RHEUMATOID-ARTHRITIS, END-STAGE RENAL-DISEASE, AND MULTIPLE-SCLEROSIS
    DEVINS, GM
    EDWORTHY, SM
    PAUL, LC
    MANDIN, H
    SELAND, TP
    KLEIN, G
    COSTELLO, CG
    SHAPIRO, CM
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 1993, 37 (02) : 163 - 170
  • [26] Side effects of alpha interferon in chronic hepatitis C
    Dusheiko, G
    [J]. HEPATOLOGY, 1997, 26 (03) : S112 - S121
  • [27] NOCTURNAL SLEEP STUDY IN MULTIPLE-SCLEROSIS - CORRELATIONS WITH CLINICAL AND BRAIN MAGNETIC-RESONANCE-IMAGING FINDINGS
    FERINISTRAMBI, L
    FILIPPI, M
    MARTINELLI, V
    OLDANI, A
    ROVARIS, M
    ZUCCONI, M
    COMI, G
    SMIRNE, S
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 125 (02) : 194 - 197
  • [28] FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135
  • [29] A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia
    Goldenberg, D
    Mayskiy, M
    Mossey, C
    Ruthazer, R
    Schmid, C
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (11): : 1852 - 1859
  • [30] A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND THROMBOCYTOPENIA
    GORDON, MS
    NEMUNAITIS, J
    HOFFMAN, R
    PAQUETTE, RL
    ROSENFELD, C
    MANFREDA, S
    ISAACS, R
    NIMER, SD
    [J]. BLOOD, 1995, 85 (11) : 3066 - 3076